All In Biotech

Free tool

FAERS Monitor: Nitrostat

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021134 or its brand name (Nitrostat, Nitroglycerin). Reports on generic versions are filed under their own applications.

Reports

50,659

Serious

39,953

79% of reports

Hospitalization

22,965

Death reported

6,683

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea4,097
  • pain3,585
  • fatigue3,446
  • myocardial infarction3,238
  • nausea3,200
  • drug ineffective2,960
  • dizziness2,873
  • chest pain2,869
  • fall2,869
  • diarrhoea2,649
  • headache2,556
  • renal failure2,467
  • death2,379
  • asthenia2,349
  • hypotension2,219

Reports by year received

View as table
YearReports
20041,000
20051,168
2006999
2007738
2008946
20091,304
20101,528
20112,468
20122,114
20131,251
20143,042
20152,372
20162,914
20172,764
20183,081
20193,145
20202,768
20212,666
20223,197
20233,162
20243,072
20252,988
20261,968

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,003,500 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
renal failureSignal2,4677.87.514,534
myocardial infarctionSignal3,2387.87.619,092
chest painSignal2,8696.56.313,303
hypotensionSignal2,2194.64.46,308
fallSignal2,8693.63.55,428
dyspnoeaSignal4,0973.02.95,643
astheniaSignal2,3492.62.52,346
painSignal3,5852.42.43,092
dizzinessSignal2,8732.42.32,387
fatigue3,4461.81.81,369
diarrhoea2,6491.71.6796
headache2,5561.71.6748
nausea3,2001.71.6914
death2,3791.11.146
drug ineffective2,9600.90.915

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.